1. Home
  2. VRCA vs EXFY Comparison

VRCA vs EXFY Comparison

Compare VRCA & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.85

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Logo Expensify Inc.

EXFY

Expensify Inc.

HOLD

Current Price

$1.55

Market Cap

110.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRCA
EXFY
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
110.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
VRCA
EXFY
Price
$5.85
$1.55
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$17.00
$4.50
AVG Volume (30 Days)
29.4K
839.7K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,577,000.00
$142,101,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
$94.44
$0.11
P/E Ratio
N/A
N/A
Revenue Growth
370.22
2.06
52 Week Low
$0.52
$0.69
52 Week High
$9.82
$2.55

Technical Indicators

Market Signals
Indicator
VRCA
EXFY
Relative Strength Index (RSI) 43.26 76.41
Support Level $5.32 $1.42
Resistance Level $6.48 $1.72
Average True Range (ATR) 0.48 0.08
MACD -0.01 0.02
Stochastic Oscillator 8.33 90.43

Price Performance

Historical Comparison
VRCA
EXFY

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app. Small and medium-sized businesses (SMBs) are the cornerstone of the global economy, making up almost all businesses and the majority of employment in Organization for Economic Co-operation and Development (OECD) member countries.

Share on Social Networks: